We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $5.49B
1-Year Est. Return 46.89%
This Fund
S&P 500
This Quarter Est. Return
+14.82%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$4.68B
AUM Growth
+$260M
Cap. Flow
+$61.4M
Cap. Flow %
1.31%
Top 10 Hldgs %
66.49%
Holding
59
New
7
Increased
15
Reduced
18
Closed
15
Avg Time Held Equity + Options
9.6 quarters
Top 10 Avg Time Held Equity + Options
9.5 quarters
Top 20 Avg Time Held Equity + Options
7.4 quarters
Avg Time Held Equity only
10.2 quarters
Top 10 Avg Time Held Equity only
9.9 quarters
Top 20 Avg Time Held Equity only
7.9 quarters

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$173M
2
CTVA icon
Corteva
CTVA
+$121M
3
DXC icon
DXC Technology
DXC
+$72.8M
4
VTRS icon
Viatris
VTRS
+$58.1M
5
THC icon
Tenet Healthcare
THC
+$55.6M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$111M
2
APTV icon
Aptiv
APTV
+$81.2M
3
TFX icon
Teleflex
TFX
+$74.8M
4
INTC icon
Intel
INTC
+$70.9M
5
FISV icon
Fiserv Inc
FISV
+$40.1M

Sector Composition

Rank Sector Weight
1 Healthcare 44.98%
2 Technology 20.65%
3 Miscellaneous 8.74%
4 Consumer Discretionary 7.14%
5 Industrials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CI icon
1
Cigna
CI
$74.7B
$642M 13.72%
2,142,526
+593,707
+38% +$173M
2013 Q2
42 quarters
THC icon
2
Tenet Healthcare
THC
$21.5B
$585M 12.51%
7,742,322
+877,180
+13% +$55.6M
2013 Q2
42 quarters
IWM icon
3
PUT
iShares Russell 2000 ETF
IWM
$77.9B
$319M 6.81%
1,587,600
+987,600
+165% +$177M
2023 Q2
2 quarters
DXC icon
4
DXC Technology
DXC
$2.04B
$297M 6.36%
13,006,623
+3,272,212
+34% +$72.8M
2017 Q2
26 quarters
UHS icon
5
Universal Health Services
UHS
$10.6B
$259M 5.55%
1,701,416
-50,000
-3% -$6.73M
2022 Q4
4 quarters
GPN icon
6
Global Payments
GPN
$21.7B
$247M 5.29%
1,948,128
+100,993
+5% +$11.7M
2020 Q4
12 quarters
CLVT icon
7
Clarivate
CLVT
$1.02B
$228M 4.88%
24,651,047
+4,472,302
+22% +$33M
2022 Q2
6 quarters
CTVA icon
8
Corteva
CTVA
$8.91B
$225M 4.81%
4,698,725
+2,529,539
+117% +$121M
2019 Q4
16 quarters
ALIT icon
9
Alight
ALIT
$243M
$155M 3.32%
910,101
+91,774
+11% +$13.6M
2022 Q3
5 quarters
MCK icon
10
McKesson
MCK
$112B
$151M 3.24%
326,896
-31,179
-9% -$14.2M
2016 Q4
28 quarters
FISV icon
11
Fiserv Inc
FISV
$24.8B
$125M 2.68%
943,277
-326,656
-26% -$40.1M
2019 Q3
17 quarters
UBER icon
12
Uber
UBER
$146B
$121M 2.59%
1,964,351
-150,000
-7% -$7.85M
2021 Q2
10 quarters
EXPE icon
13
Expedia Group
EXPE
$32.8B
$106M 2.28%
701,261
-105,874
-13% -$13M
2022 Q3
5 quarters
AMZN icon
14
Amazon
AMZN
$2.79T
$105M 2.26%
694,077
-259,972
-27% -$36.4M
2023 Q1
3 quarters
MYGN icon
15
Myriad Genetics
MYGN
$390M
$101M 2.16%
5,283,982
+1,500,000
+40% +$25.9M
2019 Q3
17 quarters
BKD icon
16
Brookdale Senior Living
BKD
$2.42B
$98.6M 2.11%
16,944,673
-1,700,000
-9% -$7.98M
2014 Q2
38 quarters
VVV icon
17
Valvoline
VVV
$3.85B
$87.2M 1.86%
2,320,173
-211,849
-8% -$7.09M
2022 Q1
7 quarters
ESI icon
18
Element Solutions
ESI
$9.07B
$87.1M 1.86%
3,762,620
+979,798
+35% +$19.8M
2016 Q3
29 quarters
USFD icon
19
US Foods
USFD
$21.2B
$79.6M 1.7%
1,753,729
-497,994
-22% -$20.6M
2021 Q4
8 quarters
HCA icon
20
HCA Healthcare
HCA
$99.8B
$68.1M 1.46%
251,516
-78,943
-24% -$19.5M
2013 Q2
42 quarters
VTRS icon
21
Viatris
VTRS
$19.8B
$65.7M 1.4%
+6,065,047
New +$58.1M
2023 Q4
0 quarters
CVS icon
22
CVS Health
CVS
$112B
$58.9M 1.26%
+746,144
New +$53.1M
2023 Q4
0 quarters
META icon
23
Meta Platforms (Facebook)
META
$1.94T
$55.6M 1.19%
157,140
+101,915
+185% +$33.2M
2023 Q3
1 quarter
CI icon
24
CALL
Cigna
CI
$74.7B
$55.2M 1.18%
184,500
-60,000
-25% -$17.5M
2023 Q2
2 quarters
KNX icon
25
Knight Transportation
KNX
$10.3B
$49.3M 1.05%
855,577
-157,261
-16% -$8.23M
2023 Q1
3 quarters
1
2 3

Similar funds

GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Glenview Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Glenview Capital Management held 59 positions worth $4.68B, up 5.9% from $4.42B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Glenview Capital Management's Q4 2023 filing shows 7 new, 15 increased, 18 reduced and 15 closed positions. Its largest new stake was Viatris: 6,065,047 shares worth $65.7M. The largest sale was Activision Blizzard, an estimated $111M.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 38% a quarter earlier, followed by Technology and Miscellaneous.

  • Glenview Capital Management's largest Q4 2023 buy was Viatris: 6,065,047 shares worth $65.7M.
  • Glenview Capital Management added most to Cigna in Q4 2023, an estimated $173M increase.
  • Glenview Capital Management's biggest Q4 2023 reduction was Intel, cutting an estimated $70.9M.
  • Glenview Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $111M.
  • Glenview Capital Management's ten largest holdings make up 66% of its $4.68B portfolio in Q4 2023.
  • Glenview Capital Management opened 7 new positions and closed 15 in Q4 2023.
  • Glenview Capital Management's portfolio value rose 5.9% quarter-over-quarter to $4.68B.

Based on Glenview Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.